RCKT β€” ROCKET PHARMACEUTICALS INC

Ownership history in Boxer Capital, LLC  Β·  28 quarters on record

This page tracks every 13F SEC filing in which Boxer Capital, LLC reported a position in ROCKET PHARMACEUTICALS INC (RCKT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
5.37% (2018 Q3)
πŸ“Š Avg. % of fund
2.03%
πŸ“… First filed
2018 Q1
πŸ“… Last filed
2024 Q4
⏱ Quarters held
28

Position Intelligence

Boxer Capital, LLC Γ— RCKT AI Analytics

πŸ“‰ Boxer Capital, LLC underperformed the S&P 500 by –29.2% annually on this RCKT position. Maximum drawdown during holding period: –77.1%.

πŸ“ˆ Position Alpha vs SPY
-29.2%
annualised excess return

❌ Significantly underperformed the S&P 500 by 29.2% ann.
7 quarters analyzed

πŸ›‘οΈ Drawdown Resilience
–77.1%
max drawdown while held

πŸ’ͺ Held through 2 major drawdowns (>20%).

πŸ’ͺ Fund Conviction
50%
buy-side decisions

1 add Β· 1 trim. Bought during 0 of 15 down-price quarters. πŸ“ˆ More buys than sells across the holding period.

πŸ“‘ Position Trajectory
↓ Shrinking
last 4–5 quarters trend

πŸ“‰ Portfolio weight has been declining in recent quarters. Possible distribution phase.
Currently 1.33% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    RCKT price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q4 UNCHANGED 1,466,051 β€” 0% 1.33% $27.1M $12.57
2024 Q3 UNCHANGED 1,466,051 β€” 0% 1.33% $27.1M $18.47
2024 Q2 UNCHANGED 1,466,051 β€” 0% 1.66% $31.6M $21.53
2024 Q1 UNCHANGED 1,466,051 β€” 0% 1.95% $39.5M $26.94
2023 Q4 UNCHANGED 1,466,051 β€” 0% 2.19% $43.9M $29.97
2023 Q3 UNCHANGED 1,466,051 β€” 0% 1.60% $30.0M $20.49
2023 Q2 UNCHANGED 1,466,051 β€” 0% 1.35% $29.1M $19.87
2023 Q1 UNCHANGED 1,466,051 β€” 0% 1.23% $25.1M $17.13
2022 Q4 UNCHANGED 1,466,051 β€” 0% 1.51% $28.7M $19.57
2022 Q3 UNCHANGED 1,466,051 β€” 0% 1.32% $23.4M $15.96
18 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding RCKT

As of 2025 Q4 β€” sorted by position size

Monaco Asset Management SAM 3Y 1.82% Lion Point Capital, LP 3Y 7Y 1.56% M28 Capital Management LP 3Y 0.98% Newtyn Management, LLC 3Y 7Y 0.98% Amitell Capital Pte Ltd 3Y 0.7% MPM BioImpact LLC 3Y 0.64% RTW INVESTMENTS, LP 3Y 7Y 0.62% Prosight Management, LP 3Y 7Y 0.54% Opaleye Management Inc. 3Y 7Y 0.44% MONIMUS CAPITAL MANAGEMENT, LP 0.32%
← Back to Boxer Capital, LLC Holdings